Chng WJ – cytomed
Menu
Home
About
About Us
Our Team
Publications
Briefs
Platform
CAR-γδ T Cell
iPSC-γδ NKT Cell
Pipeline
Manufacturer
Investor
Investor Relations
Financial Reports
Contact Us
Shareholder Benefits
Make An Appointment
Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor-modified effector cells